Proactive Investors - Run By Investors For Investors

GeoVax Labs developing a therapy that potentially cures Hepatitis B

GeoVax Labs Inc. (OTCQB:GOVX) Chairman & CEO David Dodd sat down with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco.

The clinical-stage biotechnology company is developing human vaccines against infectious diseases using its Modified Vaccinia Ankara - Virus-Like Particle (MVA-VLP) vaccine platform.

 
View full GOVX profile View Profile

GeoVax Labs Timeline

Newswire
March 07 2016
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use